Whan In Pharm Co.,Ltd. (016580.KS)
KSE · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩10,230 (+1.49%) as of
Key statistics
- Market cap
- 189.09B
- Forward P/E
- 7.16
- Dividend yield
- 2.98%
- 52-week range
- 9,160.00 – 12,140.00
- Beta
- 0.17
- Revenue (TTM)
- 273.47B
- Profit margin
- 7.48%
- Analyst target
- ₩17,000
- Volume
- 21.41k
About Whan In Pharm Co.,Ltd.
Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products, such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitamin, external preparation, medical device, and sedative, hypnotic, and autonomic nervous system medications. The company was founded in 1978 and is headquartered in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Seoul, South Korea
- Employees
- 631
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.